About Robert Geho
Form D filings for Diasome Pharmaceuticals from 2009 to 2024 list Robert Geho as chief executive officer and director.
Robert Geho first appears on SEC filings in 2009.
Experience
This experience comes from SEC filings. The years are when the filings name Robert Geho in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Robert Geho works with at each company, as listed on that company's latest Form D.
Diasome Pharmaceuticals, Inc. · Form D, Aug 15, 2024
PT
Peter Tollman
Director
FM
Frank McCaney
Director
WG
W. Geho
Executive officer and director
TM
Thomas McDonald
Director
CO
Cosme Ordonez
Director